Codeine sulfate 30 MG Oral Tablet — RxCUI 997287
RxNorm drug concept · Semantic clinical drug
RxCUI 997287
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI997287
Official nameCodeine sulfate 30 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped6
Package NDCs mapped8
Reported Medicaid activity (SDUD)849 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Codeine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Codeine Sulfate tablets are used to treat mild to moderate pain — think post-injury pain or pain after a procedure — when over-the-counter options like ibuprofen or acetaminophen h...
- You take codeine Sulfate tablets by mouth, typically every 4 hours as needed for pain. The good news is you can take it with or without food — studies show a meal doesn't meaningfu...
- How do I take it, and does it matter if I take it with food?
- The most common things people notice are drowsiness, dizziness, nausea, constipation, and sweating — these are typical opioid effects. The ones to take seriously and call 911 about...
🕸️ Concept Web — How Codeine sulfate 30 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Codeine sulfate 30 MG Oral Tablet
RxCUI 997287 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Codeine
2670IN -
Codeine sulfate
91104PIN
-
Codeine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Codeine Oral Tablet
371613SCDF -
Codeine sulfate Oral Tablet
2646508SCDFP -
Codeine Oral Product
1155185SCDG -
Codeine Pill
1155186SCDG -
Codeine sulfate Oral Product
2659350SCDGP -
Codeine sulfate Pill
2659911SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Codeine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Codeine sulfate 30 MG
997286SCDC
-
Codeine sulfate 30 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Codeine sulfate 30 MG
SCDC · 997286 -
Codeine Oral Tablet
SCDF · 371613 -
Codeine sulfate Oral Tablet
SCDFP · 2646508 -
Codeine Oral Product
SCDG · 1155185 -
Codeine Pill
SCDG · 1155186 -
Codeine sulfate Oral Product
SCDGP · 2659350 -
Codeine sulfate Pill
SCDGP · 2659911
📦 FDA Products & Package NDCs
6 products · 8 package NDCs
8 package NDCs map to RxCUI 997287 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0243-24 | 10 BLISTER PACK in 1 BOX (0054-0243-24) / 10 TABLET in 1 BL... | Codeine sulfate | Hikma Pharmaceuticals USA Inc. | 2009-07-16 |
| 00054-0244-24 | 10 BLISTER PACK in 1 BOX (0054-0244-24) / 10 TABLET in 1 BL... | Codeine sulfate | Hikma Pharmaceuticals USA Inc. | 2009-07-16 |
| 00054-0244-25 | 100 TABLET in 1 BOTTLE (0054-0244-25) | Codeine sulfate | Hikma Pharmaceuticals USA Inc. | 2009-07-16 |
| 00054-0245-25 | 100 TABLET in 1 BOTTLE (0054-0245-25) | Codeine sulfate | Hikma Pharmaceuticals USA Inc. | 2009-07-16 |
| 00527-1698-01 | 100 TABLET in 1 BOTTLE (0527-1698-01) | Codeine Sulfate | Lannett Company, Inc. | 2014-06-13 |
| 00527-1698-91 | 4 BLISTER PACK in 1 CARTON (0527-1698-91) / 25 TABLET in 1... | Codeine Sulfate | Lannett Company, Inc. | 2014-06-13 |
| 00527-1699-01 | 100 TABLET in 1 BOTTLE (0527-1699-01) | Codeine Sulfate | Lannett Company, Inc. | 2014-06-13 |
| 00527-1727-91 | 4 BLISTER PACK in 1 CARTON (0527-1727-91) / 25 TABLET in 1... | Codeine Sulfate | Lannett Company, Inc. | 2014-06-13 |
Observed labelers:
Hikma Pharmaceuticals USA Inc. (4) ·
Lannett Company, Inc. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.